• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CDKN1A: a double-edged sword in fatty liver?

作者信息

Valenti Luca, Dongiovanni Paola

机构信息

Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan, Italy; Internal Medicine; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan, Italy.

Internal Medicine; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan, Italy.

出版信息

Cell Cycle. 2014;13(9):1371-2. doi: 10.4161/cc.28754. Epub 2014 Apr 3.

DOI:10.4161/cc.28754
PMID:24699009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4050133/
Abstract
摘要

相似文献

1
CDKN1A: a double-edged sword in fatty liver?CDKN1A：脂肪肝中的一把双刃剑？
Cell Cycle. 2014;13(9):1371-2. doi: 10.4161/cc.28754. Epub 2014 Apr 3.
2
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease.细胞衰老标志物p21的基因多态性与非酒精性脂肪性肝病的疾病进展
Cell Cycle. 2014;13(9):1489-94. doi: 10.4161/cc.28471. Epub 2014 Mar 11.
3
The anti-aging promise of p21.p21的抗衰老前景。
Cell Cycle. 2017;16(21):1997-1998. doi: 10.1080/15384101.2017.1377500. Epub 2017 Sep 29.
4
Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.肝细胞衰老标志物 p21 的表达与酒精性肝病的纤维化和不良肝脏相关结局相关。
PLoS One. 2013 Sep 23;8(9):e72904. doi: 10.1371/journal.pone.0072904. eCollection 2013.
5
Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells.p21对游离脂肪酸诱导的L02细胞脂肪变性的脂毒性作用。
PLoS One. 2014 Apr 30;9(4):e96124. doi: 10.1371/journal.pone.0096124. eCollection 2014.
6
Cellular senescence in liver diseases: From mechanisms to therapies.肝脏疾病中的细胞衰老：从机制到治疗。
Int Immunopharmacol. 2023 Aug;121:110522. doi: 10.1016/j.intimp.2023.110522. Epub 2023 Jun 27.
7
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.IGF-I 通过依赖 p53 的方式诱导肝星状细胞衰老并限制纤维化。
Sci Rep. 2016 Oct 10;6:34605. doi: 10.1038/srep34605.
8
Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway.日本血吸虫可溶性虫卵抗原通过激活STAT3/p53/p21信号通路诱导活化的肝星状细胞衰老。
Sci Rep. 2016 Aug 4;6:30957. doi: 10.1038/srep30957.
9
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.CDK4/6 抑制剂在衰老中替代 p21 和 p16：细胞周期阻滞的持续时间和 MTOR 活性决定了衰老的转化。
Cell Cycle. 2013 Sep 15;12(18):3063-9. doi: 10.4161/cc.26130. Epub 2013 Aug 22.
10
Promotion of cellular senescence by THG-1/TSC22D4 knockout through activation of JUNB.通过激活 JUNB，THG-1/TSC22D4 敲除促进细胞衰老。
Biochem Biophys Res Commun. 2020 Feb 19;522(4):897-902. doi: 10.1016/j.bbrc.2019.11.145. Epub 2019 Dec 3.

引用本文的文献

1
Aged-related Function Disorder of Liver is Reversed after Exposing to Young Milieu Conversion of Hepatocyte Ploidy.暴露于年轻环境后，肝细胞倍性转换可逆转衰老相关的肝脏功能障碍。
Aging Dis. 2021 Aug 1;12(5):1238-1251. doi: 10.14336/AD.2020.1227. eCollection 2021 Aug.
2
Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis.抑制 cdk4-C/EBPα-p300 轴消除与年龄相关的肝脂肪变性并纠正衰老表型。
Cell Rep. 2018 Aug 7;24(6):1597-1609. doi: 10.1016/j.celrep.2018.07.014.
3
Telomeres, NAFLD and Chronic Liver Disease.

本文引用的文献

1
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease.细胞衰老标志物p21的基因多态性与非酒精性脂肪性肝病的疾病进展
Cell Cycle. 2014;13(9):1489-94. doi: 10.4161/cc.28471. Epub 2014 Mar 11.
2
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的遗传易感性：对肝脏疾病严重程度和治疗反应的影响。
Curr Pharm Des. 2013;19(29):5219-38. doi: 10.2174/13816128113199990381.
3
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
端粒、非酒精性脂肪性肝病与慢性肝病
Int J Mol Sci. 2016 Mar 15;17(3):383. doi: 10.3390/ijms17030383.
4
Modulation of insulin degrading enzyme activity and liver cell proliferation.胰岛素降解酶活性与肝细胞增殖的调节
Cell Cycle. 2015;14(14):2293-300. doi: 10.1080/15384101.2015.1046647. Epub 2015 May 6.
5
Cross-species toxicogenomic analyses and phenotypic anchoring in response to groundwater low-level pollution.跨物种毒理基因组学分析及对地下水低水平污染反应的表型锚定
BMC Genomics. 2014 Dec 5;15(1):1067. doi: 10.1186/1471-2164-15-1067.
肝细胞衰老预测非酒精性脂肪性肝病的进展。
J Hepatol. 2013 Mar;58(3):549-56. doi: 10.1016/j.jhep.2012.10.031. Epub 2012 Nov 8.
4
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.新型端粒酶突变合并脂肪变性患者的肝移植治疗肝细胞癌。
J Hepatol. 2013 Feb;58(2):399-401. doi: 10.1016/j.jhep.2012.09.011. Epub 2012 Sep 19.
5
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.载脂蛋白样磷脂酶 3/脂联素 I148M 基因多态性纯合子影响非酒精性脂肪性肝病患者的肝纤维化。
Hepatology. 2010 Apr;51(4):1209-17. doi: 10.1002/hep.23622.
6
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.PNPLA3基因变异会使人易患非酒精性脂肪性肝病。
Nat Genet. 2008 Dec;40(12):1461-5. doi: 10.1038/ng.257. Epub 2008 Sep 25.
7
From fat to inflammation.从脂肪到炎症。
Gastroenterology. 2006 Jan;130(1):207-10. doi: 10.1053/j.gastro.2005.11.017.